WallStreetZenWallStreetZen

NASDAQ: SBFM
Sunshine Biopharma Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

SBFM past revenue growth

How has SBFM's revenue growth performed historically?
Company
186.53%
Industry
266.89%
Market
21.77%
SBFM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SBFM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SBFM's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SBFM earnings and revenue history

Current Revenue
$490.9k
Current Earnings
-$2.6M
Current Profit Margin
-522.5%

SBFM Return on Equity

Current Company
-10.7%
Current Industry
12.4%
Current Market
-9.5%
SBFM's Return on Equity (-10.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SBFM announces earnings.

SBFM Return on Assets

Current Company
-10.4%
Current Industry
3.8%
SBFM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SBFM Return on Capital Employed

Current Company
-6.23%
Current Industry
7.9%
SBFM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SBFM vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SBFM$490.88k-$2.51M-$2.57M+52.33%N/A
PAVS$95.59M-$56.22M-$58.51M+79.21%N/A
LCI$308.52M-$105.90M-$192.52M-13.58%N/A
BFRI$28.67M$759.00k-$640.00k+45.66%N/A
ZYNE$0.00-$35.61M-$35.83M-100.00%N/A
View Top Pharmaceutical Stocks

Sunshine Biopharma Earnings & Revenue FAQ

What were SBFM's earnings last quarter?

Sunshine Biopharma (NASDAQ: SBFM) reported Q3 2022 earnings per share (EPS) of -$0.08, up 94.97% year over year. Total Sunshine Biopharma earnings for the quarter were -$1.46 million. In the same quarter last year, Sunshine Biopharma's earnings per share (EPS) was -$1.59.

If you're new to stock investing, here's how to buy Sunshine Biopharma stock.

What was SBFM's earnings growth in the past year?

As of Q1 2023, Sunshine Biopharma's earnings has grown year over year. Sunshine Biopharma's earnings in the past year totalled -$2.57 million.

What was SBFM's revenue last quarter?

Sunshine Biopharma (NASDAQ: SBFM) reported Q3 2022 revenue of $132.81 thousand up 163.63% year over year. In the same quarter last year, Sunshine Biopharma's revenue was $50.38 thousand.

What was SBFM's revenue growth in the past year?

As of Q1 2023, Sunshine Biopharma's revenue has grown 186.53% year over year. This is 80.36 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 266.89%. Sunshine Biopharma's revenue in the past year totalled $490.88 thousand.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.